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Significant dose reduction using 
synchrotron radiation computed 
tomography: first clinical case and 
application to high resolution CT 
exams
H. Labriet1,2, C. Nemoz3, M. Renier3, P. Berkvens3, T. Brochard3, R. Cassagne2, H. Elleaume2, 
F. Estève1,2, C. Verry1, J. Balosso1,2, J. F. Adam1,2 & E. Brun2
Since the invention of Computed Tomography (CT), many technological advances emerged to improve 
the image sensitivity and resolution. However, no new source types were developed for clinical use. In 
this study, for the first time, coherent monochromatic X-rays from a synchrotron radiation source were 
used to acquire 3D CTs on patients. The aim of this work was to evaluate the clinical potential of the 
images acquired using Synchrotron Radiation CT (SRCT). SRCTs were acquired using monochromatic 
X-rays tuned at 80 keV (0.350 × 0.350 × 2 mm3 voxel size). A quantitative image quality comparison 
study was carried out on phantoms between a state of the art clinical CT and SRCT images. Dedicated 
iterative algorithms were developed to optimize the image quality and further reduce the delivered 
dose by a factor of 12 while keeping a better image quality than the one obtained with a clinical 
CT scanner. We finally show in this paper the very first SRCT results of one patient who received 
Synchrotron Radiotherapy in an ongoing clinical trial. This demonstrates the potential of the technique 
in terms of image quality improvement at a reduced radiation dose for inner ear visualization.
Computed Tomography (CT) - with 62 million exams performed each year in the USA - is the most common 
clinical examination using the principle of X-ray attenuation1 and the most frequently used 3D medical diagnos-
tic tool yielding to an increased overall radiation dose delivered to patients for medical purposes. Recent studies 
estimated that 3% of cancers may be attributable to diagnostic CT2 and that a cumulative dose of 50 mGy in 
childhood triples the risk of brain tumor and leukemia3.
Since its invention and the seminal work performed by Hounsfield and Cormack4, many technologi-
cal advances emerged to improve the image sensitivity and the spatial resolution5. However, to the best of our 
knowledge, no new source type was developed for clinical use despite the current limitations of conventional 
bremsstrahlung x-ray sources, such as low flux, strong divergence, broad energy spectrum and associated arti-
facts, drift or heating problems.
In the past two decades synchrotron radiation has shown its potential in biomedical imaging6 mainly in mam-
mography7 or in musculo-skeletal applications8. Synchrotron Radiation Computed Tomography (SRCT) became 
then the gold standard technique for measuring 3D linear attenuation coefficients9. However, until now all these 
biomedical studies were limited to human anatomical pieces or to preclinical studies on small animals.
In this work we first evaluate both quantitatively and qualitatively the performance of SRCT on quality assur-
ance phantoms to show that significant dose reduction can be achieved with improved image quality. The second 
part of the paper is devoted to the clinical SRCT results on a patient with a focus on high resolution inner ear 
exam at a low dose.
1Centre Hospitalier Universitaire de Grenoble, avenue Maquis du Grésivaudan, 38700, La Tronche, France. 
2Rayonnement Synchrotron et Recherche Médicale, EA 7442, Université Grenoble-Alpes, Grenoble, France. 
3European Synchrotron Radiation Facility, 71 avenue des Martyrs, 38043, Grenoble, France. Correspondence and 
requests for materials should be addressed to J.F.A. (email: adam@esrf.fr)
Received: 27 October 2017
Accepted: 7 August 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts |  (2018) 8:12491  | DOI:10.1038/s41598-018-30902-y
Methods
The SRCT images were acquired in the context of patient positioning in an on-going phase I/II contrast enhanced 
synchrotron stereotactic radiotherapy (SSRT) clinical trial performed at the European Synchrotron Radiation 
Facility (ESRF) biomedical beamline (ID17).
The procedures followed in the present study were in accordance with the ethical standards of the responsible 
committee on human experimentation: the regional ethical committee designed by the French ministry of health 
approved our protocol before any patient recruitment (comité de protection des personnes sud est V, CS10217, 
38043 Grenoble cedex 9, France), refs CPP-10CHUG09 and 2010-A00773-36. Each recruited patient signed an 
informed consent form prior to their inclusion in the present study.
The experimental set-up used for SRCT and its comparison with a conventional X-ray CT scanner are shown 
in Fig. 1.
In a conventional clinical set-up, both the source and the detector rotate around the patient. In SRCT, the 
patient is rotated on an axis perpendicular to the beam propagation. The SRCT X-ray beam is monochromatic 
with an energy tunable between 30 and 120 keV (1‰ bandwidth) and quasi-parallel (<1mrad divergence), whilst 
commercial CT scanners use fan or cone shaped polychromatic beams. The quasi-parallel beam is indeed unique 
and exhibits advantages over the fan or cone shaped beam. For example, interpolation is not required for the 
tomographic reconstruction algorithm. The synchrotron storage ring is a 6 GeV machine and the x-rays are pro-
duced using two multipole wigglers located 150 m from the patient positioning system. An electron ring current 
of about 200 mA was used for our experiment. The focal source size is 60 µm (full half width maximum). The 
beam at the patient level is 150 mm wide, 2 mm height and can be considered as parallel.
For the sake of comparison conventional images were acquired on a recent diagnostic scanner (GE Healthcare 
Revolution, Chicago, USA) available from the local neuroradiology department. The hospital CT operated at 120 kVp 
in helical mode (pitch = 0.53) with fixed mAs, a FOV of 22.5 cm and a 512 × 512 pixels matrix (0.44 mm pixel size) 
for the whole study.
Two imaging protocols were used on the conventional CT:
•	 a standard head CT protocol: 200 mAs, 1.25 mm slice thickness, CTDI = 33 mGy.
•	 an inner ear CT protocol, to obtain the highest resolution achievable for diagnostic routine exams: 350 mAs 
CTDI = 183 mGy.
The dose for both clinical CT and SRCT was measured using a calibrated PTW (Freiburg Germany) CT ion-
ization chamber (PTW 31336) within a head phantom, standard head CTDI, (IBA Dosimetry, Germany) in a 
cylindrical volume of 16 cm in diameter with a 1 cm scan in height.
Figure 1. Presentation of the clinical (a) and the synchrotron radiation (b) computed tomography set-up. At 
the hospital a cone or fan beam and the detectors are rotating around the patients whilst at the synchrotron the 
patient is sat on a moving and rotating chair.
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The SRCT configuration used a 150 mm wide, 2 mm height 80 keV X-ray beam10. The detector was positioned 
6 m downstream of the patient. A high purity germanium detector composed of 431 pixels (350 µm in width) 
was used in current integration mode (2 ms integration time per projection). The radiotherapy photon flux was 
reduced by adding PolyMethyl MethAcrylate (PMMA) attenuators of various thicknesses (0.5 to 32.5 cm). A 
so-called half-acquisition mode11 was used to raise the reconstruction field of view to 28 cm. We acquired 1024 
projections around 360 degrees at the rotation speed of 87.5 degrees/s. Due to the laminar shape of the beam the 
imaging acquisition protocol consists of several rotations followed by vertical movements in order to scan the 
patient region of interest. The total imaging acquisition time for the patient was 123 s for 30 slices.
For this study two imaging protocols were used at the ESRF:
•	 The low dose imaging protocol: slice thickness 0.625 mm, 18 cm PMMA attenuators. We then virtually 
removed 2/3 of the projections and present 340 projections reconstructions with CTDI = 14.8 mGy.
•	 The SSRT clinical trial imaging protocol using no modifications from the treatment beam geometry to the 
imaging beam, except flux reduction: slice thickness 2 mm, 14.5 cm PMMA attenuators, CTDI = 93 mGy.
A Catphan 504 (PhantomLab, Salem, NY, USA) was used to compare quantitatively the SRCT images with 
the gold standard clinical CT. The different acquisition protocols are summarized in Table 1. Raw images were 
first reconstructed by a simple filtered back projection algorithm12 and processed using the Normalized Metal 
Artifact Reduction13 approach to remove artifacts caused by patient positioning seeds. 340 projections were cho-
sen as approximatively 1/3 of the original number of projections, and being a value mathematically suitable for 
the EST. At 340 projections, the images (patient and phantom) still exhibits an improved quality when compared 
to conventional CT (as detailed in the results section). Using a lower number of projections start to impair the 
image quality.
In order to further increase the SNR in soft tissues whilst keeping a high image quality in the bone tissues, we 
implemented a multi-component reconstruction procedure. For each sinogram, we process bone and soft tissue 
components separately with adapted filters and reconstruction parameters. Starting from the raw reconstruction, 
i.e., standard Filtered Back Projection, we segment each tissue by thresholding. After segmentation, a projection 
operator is used to obtain the radiographs for each tissue. A low-pass filter is then applied in the Fourier domain 
for each radiograph. We empirically adapted for each tissue the kernel sizes according to its softness. A classical 
Filtered Back Projection algorithm is then applied to obtain each tissue CT images. In order to reproduce the 
entire volume, the CT data are then merged in one single volume using the masks generated by the original 
segmentation.
Figure 2 presents a flowchart of this iterative image reconstruction algorithm.
To evaluate the possibility of further dose reduction, we virtually minimized the number of projections (340 
instead of 1024) and used an iterative reconstruction algorithm: Equally Sloped Tomography (EST) which has 
shown high potential when the number of projections is low7,14,15. For further details of the EST method please 
refer to7. Altogether SRCT with EST reconstruction achieve a CTDI of 14.8 mGy.
The Signal to Noise Ratio (SNR) (Eq. 1) and Contrast to Noise Ratio (CNR) (Eq. 2) were measured in the 
homogenous and low contrast modules, using the following definitions:
=
σ
µSNR (1)
µ µ
=
−
σ
CNR (2)
1 2
where µ is the average Hounsfield value in homogeneous ROI and σ is the standard deviation in the considered 
ROI; µ1 and µ2 are defined as average Hounsfield values in two different homogenous zones. These measurements 
of CNR and SNR were made on 4 ROIs in the Catphan image. The spatial resolution was estimated visually using 
the MTF (Modulation Transfer Function) module by a trained x-ray examiner.
Finally, one patient bearing a brain metastasis close to the inner ear has been imaged during the positioning 
and contrast agent uptake verification procedure in the framework of the SSRT clinical trials. The imaging acqui-
sition parameters, such as energy, spatial resolution, slice thickness and flux, were defined by the radiotherapy 
trial constraints and thus could not be optimized, as it would be the case for an imaging clinical trial.
Acquisition protocols Energy
PMMA 
thickness
Slice 
thickness
Pixel 
size
Number of 
projections
Dose 
CTDI
(cm) (mm) (mm) (−) (mGy)
Conventional 
clinical CT
Standard head (patient)
120 kVp
n.a. 1.25 0.44 n.a 33
250 mA
Inner ear (phantom)
120 kVp
n.a. 0.625 0.44 n.a 183
350 mA
SR-CT
Patient acquisition
80 keV
14.5 2 0.35 1024 93
191 mA
‘Low dose’ (phantom) 80 keV 18 0.625 0.35 340 14.8
Table 1. Acquisition and CTDI parameters of the various scans performed in this comparative study.
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Results
Figure 3 shows both the high resolution MTF and the low contrast modules reconstruction for two acquisitions, 
inner ear conventional CT and low dose SRCT reconstructed by the EST method using 340 projections. From 
these images, it is clear that SRCT at a reduced dose outperforms the state-of-the-art clinical CT in term of image 
quality for the inner ear protocol.
Figures a and b present the resolution module of the Catphan with a zoom in the harder part to distinguish. 
Images c and d present the low contrast module with the 3 groups of contrast. The improvement of the contrast 
between the different inserts is visible in Fig. 3(c and d). The catphan phantom has a low contrast module with 
supra-slice and subslice contrast targets. The low contrast targets have different diameters and contrasts. The 
subslice target diameters range from 3.0 mm to 9.07 mm. The contrast of the 3 groups are 1%, 0.5% and 0.3% dif-
ference in attenuation with the background slice. Two groups of inserts can be seen in both modalities but in the 
SRCT image a difference can be noted between the 0.5% and the 1%. The high resolution module with 21 line pair 
per cm gauge of the catphan allows evaluation of the resolution obtained. This module section has a set of high 
Figure 2. Scheme of the reconstruction algorithm for improving the SNR on SRCT images.
Figure 3. Images acquired on the Catphan 504 phantom. MTF module on the top (a and b) and low contrast 
module on the bottom (c and d) (a and c) are acquired at the hospital with the inner ear protocol (CTDI 
183mGy). (b and d) were acquired at the ESRF with low dose reconstruction (CTDI 14.8mGy). The region of 
interest where the image quality parameters were measured (12 mm diameter) are represented with red circles.
www.nature.com/scientificreports/
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resolution patterns in pair of line per cm. Figure 3(a and b) demonstrate the improved resolution achieved by the 
SRCT. It is particularly interesting to note that the low dose reconstruction succeeds in improving the resolution 
by 4 line pairs per mm (from 11 to 15) in comparison with the inner ear clinical protocol whilst the dose to the 
sample has been reduced by a factor 12.
Table 2 summarizes the quantitative results obtained on the Catphan phantom for the central background ROI 
(worth scenario for SNR or CNR considering the artifacts seen on Fig. 3). Both resolution and signal to noise ratio 
are greater for the two SRCT acquisitions when compared to the clinical acquisitions for each ROI described on 
Fig. 3. The SNR is multiplied by at least a factor 20 between the two high resolution protocols. The CNR is slightly 
improved.
Figure 4(a and b) show the SRCT reconstructed image of the inner ear of one patient, using 1024 projections 
and 340 projections, respectively. The patient was immobilized in a stereotactic frame using a thermoform mask 
(Brainlab, Munich, Germany). We note that the virtual dose reduction can be achieved without image quality 
deterioration. The bone structure is well depicted in the both images. If we zoom in the inner ear structure, we can 
appreciate the resolution achieved in the temporal bones. We can clearly see the common cystic cavity, the inter-
nal acoustic meatus and all the air cells in the mastoid bone for example. The image quality is improved even if the 
number of projection is reduced. Please note that the slice thickness of the images is 2 mm due to the radiotherapy 
trial safety constraint. It is for this reason that the images of the inner ear do not show a substantial improvement 
if compared to a standard clinical inner ear CT. Nevertheless, the slice thickness in the SRCT protocol can be fur-
ther reduced without increasing the radiation dose as we demonstrated for the phantom. Moreover, we can expect 
a further reduction by lowering the photon flux, which was not possible on the patient within the clinical trial.
Discussion and Conclusion
Imaging plays an increasing key role in the diagnosis and in the management of the numerous head and neck 
diseases. X-ray CT is the most commonly used examination and corresponds to the most important part of the 
population’s artificial ionizing radiation exposure. Although the risks associated withone exam remain low, the 
increased lifetime can lead to a public health hazard in the future2. During the last few years, the number of diag-
nostic CT examinations performed has increased dramatically. Many efforts have been made by manufacturers 
Figure 4. Patient SRCT slices reconstructed with 1024 (a) projections using the EST algorithm; The image (b) 
was reconstructed using 340 projections over the available 1024 projections.
Acquisition protocols CNR SNR MTF (pl/mm) CTDI (mGy)
Conventional CT
Standard head 1.94 13.02 10 33
Inner ear 1.26 10.33 11 183
SR-CT
Patient acquisition 4.46 540.06 15 93
‘Low dose’ (340 
projections, EST) 1.91 217.65 15 14.8
Table 2. Contrast to Noise Ratio, Signal to Noise Ratio and resolution for the different acquisition protocols 
(central background ROI). EST: Equally Sloped Tomography. CNR: Contrast to Noise Ratio. SNR: Signal to 
Noise Ratio. MTF: Modulation Transfer Function. CTDI: Computed Tomography Dose Index.
www.nature.com/scientificreports/
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to decrease the dose in a single exam by using iterative reconstruction algorithms and/or more efficient detectors. 
However, to the best of our knowledge, no significant attempt has been made to use other types of X-ray sources 
on patients.
Conventional CT is limited for the detection and visualization of small variations in brain tissues mass densi-
ties, due to the small differences of mass attenuation coefficients between the soft tissues. That’s why conventional 
CT generally requires the use of iodine as contrast agent to improve visualization. The problem in using contrast 
agents is not only limited to CT exams, but to MRI as well, which often requires the injection of gadolinium-based 
contrast agents. Recent discoveries showed that some free gadolinium, which is highly toxic, persists in the brain 
of patients after several injections16. Moreover, it has been recently shown that MRI combined with the injection 
of gadolinium may lead to additional DNA double strand breaks17. Developing new types of diagnostic imaging 
modalities like SRCT that do not always require the use of contrast agents and operate at a lower radiation dose 
appears thus as an option to be seriously considered in diagnostic radiology.
The aims of this study were to evaluate the performance and the potential of synchrotron radiation CT using 
tunable monochromatic low divergence X-rays. This study was performed on a quality assurance phantom as well 
on a patient involved in an ongoing radiotherapy program clinical trial at the ESRF.
According to the IRSN (“Institut de Radioprotection et de Sureté Nucléaire”, the French Regulator) the dose 
routinely delivered in hospitals for a head diagnosis CT is 65 mGy18. Our study shows that the delivered doses 
could be significantly reduced while increasing the global image quality thanks to the combination of small pixel 
size, high spatial coherence, monochromaticity, and negligible scatter detection due to the long distance between 
the patient and the detector.
Altogether, if we combine the high performances of the synchrotron source, the EST reconstruction and the 
flux reduction prospect, we would obtain a dose reduced by a factor 12 when compared to the state-of-the-art 
clinical CT. This is of particular interest for high-resolution head & neck CTs. The use of such an iterative recon-
struction algorithm is also possible outside the synchrotron world and can be applied on clinical datasets19.
Even if the trial has not been designed specifically for imaging, these SRCT data sets on patients are the first 
ever obtained on humans with a synchrotron source and clearly show the potential of SRCT in clinical high reso-
lution imaging at a reduced radiation dose. Performing CT using a synchrotron source is thus feasible in clinics, 
even if scanning the brain region. It allows to resolve complex bone structures at a lower dose than clinical routine 
protocols. This is by itself a significant added value x-ray CT imaging.
In the past two decades synchrotron radiation has shown its potential in biomedical imaging6: in mammogra-
phy, for the diagnosis of human breast cancers7,20, on human knee8 and other types of tissue6. SRCT became then 
the gold standard technique for measuring 3D linear attenuation coefficients9. Until now these biomedical studies 
were limited to human anatomical samples or to preclinical studies on small animals9,21. The SYRMA-CT/3D22 
(SYnchrotron Radiation- MAmmography-Computed Tomography/three-Dimensional) collaboration aims to 
set-up the first clinical trial of PhC breast CT with SR. This phase 1 clinical trial on mammography has been 
set-up in Trieste in 2016 with the aim of resolving questionable diagnosis after the hospital exam, based on con-
ventional mammography and ultrasound. Moreover, as the radiotherapy clinical trial associated to the current 
study requires the injection of 200–250 mL of iodinated contrast agent, it is completely safe to proceed with 
SR-CT after injection of a quite large amount of contrast agent as it could be required by osteoarticular or oncol-
ogy studies. Phase contrast CT imaging techniques are promising as the natural contrast is enhanced. This raises 
the question if a proper diagnosis could be performed without injection of contrast agent and thus avoid adverse 
side effects. However further SR-CT studies should be performed on patients, with and without contrast admin-
istration, with clear endpoints in terms of sensitivity and specificity assessment to reply to that complex question. 
It is too early to make any statement and the answer might be pathology or anatomy dependent.
All these results encourage imaging with new types of X-ray sources where monochromaticity and coherence 
are made possible to spread it outside the synchrotron world where beamtime access could be a serious limitation. 
New source types which are more compact than a synchrotron are currently in their development phase in this 
direction23, for a wider development of the technique in an environment closer to the hospital one. This proof 
of concept study allows us to envisage a wider spread use of highly coherent X-ray sources because the results 
show a higher image quality at a lower radiation dose deposition. A transfer of the technique to other sources is 
an essential step to consider a clinical application. Currently new compact X-ray sources such as ThomX23 are in 
development. The goal of the ThomX project is to design and build a facility with a flux between 1011–1013 γ/s in 
the hard X-ray range and the photon energy tunability will provide a Compton edge that can be set between 50 
and 90 keV. Such sources have synchrotron-like characteristics in terms of brightness and coherence24 and will 
provide a much larger accessibility to the technique.
The study presented in this paper shows the very first live human CT dataset obtained on a synchrotron source 
and will undoubtedly pave the way of a wider development of monochromatic and coherent x-ray imaging tech-
niques for various medical applications such as oncology or osteo-articular diseases.
Data availability. All data generated or analysed during this study are included in this published article.
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